Migraine Medication Effects on Urinary Symptoms

NCT06212661 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder
Bladder Pain Syndrome
Migraine Disorders
Overactive Bladder Syndrome
Overactive Detrusor
Migraine
Interstitial Cystitis

Interventions

DRUG: Ubrogepant
DRUG: Rimegepant
DRUG: Atogepant
DRUG: Eptinezumab
DRUG: Fremanezumab
DRUG: Galcanezumab
DRUG: Erenumab
DRUG: Botulinum toxin A

Sponsor

The Cleveland Clinic